Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.73 [0.6-0.89],0.00233929988854587,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.33 [0.15-0.73],0.0061099377846775,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.57 [1.12-2.2],0.00836832434657468,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,8.73 [1.52-50.24],0.0151937877227252,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,0.6 [0.4-0.92],0.0187600850617441,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.76 [0.6-0.97],0.026836866912504,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.19 [1.02-1.39],0.0279050314699929,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.42 [1.04-1.94],0.0285783812591682,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.71 [0.52-0.97],0.0295636765991441,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,0.79 [0.64-0.98],0.0310235781490712,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,14.75 [1.22-178.05],0.0341565165388925,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.94 [1.05-3.58],0.0348899139947831,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.8 [0.65-0.99],0.0364832057678356,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.25 [1.01-1.55],0.0380101203976714,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPON1,Spondin-1,Inverse variance weighted,21,0.76 [0.59-0.99],0.0405839533811416,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KLK6,Kallikrein-6,Inverse variance weighted,4,0.62 [0.39-0.99],0.0453104152546391,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.86 [0.74-1],0.0461280474771594,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,0.89 [0.8-1],0.0465137670078262,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.39 [1-1.92],0.0470948460636358,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CALCA,Calcitonin,Inverse variance weighted,5,2.08 [1-4.34],0.0510483820008431,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.87 [0.76-1],0.0534221330721147,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.26 [1-1.59],0.0541765256419475,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.74 [0.54-1.01],0.0606019733984368,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,0.79 [0.62-1.01],0.061800248575716,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.14 [0.99-1.32],0.0619874809195614,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD83,CD83 antigen,Inverse variance weighted,5,1.57 [0.98-2.54],0.0632731626053167,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.24 [0.05-1.09],0.0643954692421276,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.53 [0.27-1.04],0.0645571460332605,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.24 [0.99-1.56],0.0649909754838522,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.67 [0.43-1.03],0.0652763520170497,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.72 [0.96-3.06],0.0666015170336023,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.88 [0.76-1.01],0.0767175627191397,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,2.02 [0.92-4.42],0.0779643115329122,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.68 [0.44-1.05],0.0797674619979055,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.78 [0.91-3.47],0.0916809054999815,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.85 [0.69-1.03],0.0922806724481087,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.28 [0.96-1.72],0.0958877836823676,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.41 [0.14-1.17],0.0963332901808491,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.22 [0.96-1.55],0.10116889943484,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.29 [0.95-1.74],0.103978264788454,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PENK,Proenkephalin-A,Inverse variance weighted,19,0.82 [0.64-1.05],0.109155477883699,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,UMOD,Uromodulin,Inverse variance weighted,29,1.1 [0.97-1.24],0.12576843423388,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.28 [0.93-1.76],0.126295301421692,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.87 [0.72-1.04],0.1336691975627,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REN,Renin,Inverse variance weighted,4,1.29 [0.92-1.81],0.134639521993787,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,3.76 [0.65-21.61],0.138085828686928,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PI3,Elafin,Inverse variance weighted,10,1.26 [0.93-1.71],0.13848081533644,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SHISA5,Protein shisa-5,Inverse variance weighted,5,2.05 [0.79-5.33],0.141259209571963,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.25 [0.93-1.68],0.146456146323048,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,12,1.25 [0.92-1.69],0.151453299128808,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.35 [0.89-2.05],0.15163207997843,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,COLEC12,Collectin-12,Inverse variance weighted,11,1.29 [0.91-1.85],0.157469071712666,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.81 [0.61-1.08],0.157846602004777,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.36 [0.89-2.08],0.16116474241546,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.24 [0.03-1.81],0.164838575401672,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,2.06 [0.74-5.73],0.166831584134157,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,0.91 [0.79-1.04],0.174354130417669,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.2 [0.92-1.57],0.176106913935714,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.12 [0.95-1.32],0.182160690562796,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.52 [0.82-2.81],0.183525298225205,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MMP7,Matrilysin,Inverse variance weighted,13,1.19 [0.92-1.54],0.187827987200539,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.32 [0.87-2.02],0.191955268129372,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.84 [0.65-1.09],0.192774758052802,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.12 [0.94-1.33],0.194848838697265,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.21 [0.91-1.62],0.196101781248359,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.86 [0.69-1.08],0.19694585213073,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.79 [0.55-1.13],0.198571982056684,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.71 [0.74-3.97],0.2080467895801,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CX3CL1,Fractalkine,Inverse variance weighted,9,1.33 [0.85-2.05],0.208293457546842,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PSAP,Prosaposin,Inverse variance weighted,5,0.72 [0.44-1.2],0.208968045904562,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,1.27 [0.87-1.84],0.209892618781596,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HSPB6,Heat shock protein beta-6,Wald ratio,1,4.59 [0.42-49.65],0.210010504274856,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.55 [0.22-1.4],0.210124479711417,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD27,CD27 antigen,Inverse variance weighted,9,1.19 [0.9-1.57],0.211194363211109,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PGA4,Pepsin A-4,Inverse variance weighted,2,0.45 [0.13-1.58],0.211254902356779,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,BSG,Basigin,Wald ratio,1,1.55 [0.78-3.09],0.212874774836298,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.33 [0.85-2.09],0.215201653763746,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,1.09 [0.95-1.27],0.227222663901213,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.14 [0.91-1.42],0.24159536753435,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.44 [0.78-2.66],0.244175315262809,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.12 [0.92-1.37],0.254796917731698,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.79 [0.52-1.19],0.255009927045175,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.42 [0.1-1.86],0.255153941395897,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.28 [0.03-2.53],0.257862436790441,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.12 [0.92-1.38],0.259804833425524,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.28 [0.03-2.67],0.270337009915047,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.81 [0.62-5.27],0.274799861196487,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.64 [0.29-1.43],0.278188281476931,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,2 [0.57-7.02],0.280903393603357,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1.35 [0.77-2.37],0.287636990354519,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.87 [0.67-1.13],0.295192031833016,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.83 [0.58-1.18],0.302488960782083,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NPPC,C-type natriuretic peptide,Wald ratio,1,3.27 [0.34-31.92],0.307878401135506,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,0.85 [0.62-1.17],0.318391764263515,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DSC2,Desmocollin-2,Inverse variance weighted,9,0.84 [0.6-1.18],0.31985247537547,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RETN,Resistin,Inverse variance weighted,9,0.91 [0.74-1.1],0.321048961028033,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.85 [0.62-1.17],0.322969518746746,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.92 [0.79-1.08],0.325058724669107,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.67 [0.3-1.5],0.327323654573832,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.83 [0.57-1.21],0.330690017157307,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD160,CD160 antigen,Inverse variance weighted,11,1.13 [0.89-1.43],0.331183643503937,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.49 [0.67-3.31],0.332355434238346,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FAM3C,Protein FAM3C,Inverse variance weighted,2,2.2 [0.44-11.11],0.339503877208046,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.96 [0.87-1.05],0.340421211141402,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.85 [0.61-1.19],0.342744896620689,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,3.67 [0.24-55.73],0.348607740598764,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.74 [0.4-1.39],0.349210489695062,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RSPO3,R-spondin-3,Inverse variance weighted,6,1.26 [0.77-2.07],0.350400050374213,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.14 [0.86-1.52],0.350570317496832,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KLK11,Kallikrein-11,Inverse variance weighted,6,0.91 [0.75-1.11],0.352029123350481,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.77 [0.45-1.33],0.35208690242931,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.78 [0.47-1.31],0.355391218299113,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EDN1,Endothelin-1,Inverse variance weighted,3,0.8 [0.51-1.28],0.356042143333118,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CSTB,Cystatin-B,Inverse variance weighted,28,0.91 [0.74-1.11],0.357379464142833,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.35 [0.71-2.57],0.357466778602614,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.79 [0.51-6.25],0.363794580365707,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.95 [0.84-1.07],0.363796324037036,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.06 [0.93-1.21],0.36834910622611,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.1 [0.89-1.37],0.36973094039379,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.95 [0.84-1.07],0.374972254163037,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.9 [0.71-1.14],0.377399780585554,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.19 [0.81-1.75],0.378800151893291,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,AMBP,Protein AMBP,Inverse variance weighted,3,1.33 [0.7-2.5],0.380813837132606,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.81 [0.51-1.3],0.384007875702455,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPON2,Spondin-2,Inverse variance weighted,4,0.84 [0.56-1.26],0.394498793574152,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.54 [0.13-2.25],0.39501919662272,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.94 [0.83-1.08],0.395729407501846,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.21 [0.78-1.87],0.398709366138337,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.23 [0.76-2.01],0.398746863301559,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.84 [0.55-1.27],0.409900104412118,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.28 [0.71-2.32],0.416242084612056,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.78 [0.42-1.43],0.423315744815508,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCN3,CCN family member 3,Inverse variance weighted,19,0.88 [0.64-1.21],0.430844919297323,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.73 [0.33-1.61],0.433255781448834,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.89 [0.66-1.19],0.434872841960831,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.33 [0.64-2.76],0.439133875438016,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.79 [0.43-1.45],0.447724169926698,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.79 [0.43-1.45],0.44833342326767,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCG2,Secretogranin-2,Wald ratio,1,0.46 [0.06-3.46],0.45238987704345,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.6 [0.47-5.46],0.455533523094723,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.79 [0.42-1.48],0.461768945737387,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRSS2,Trypsin-2,Inverse variance weighted,3,0.77 [0.38-1.56],0.462676199655863,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.88 [0.62-1.25],0.465565942410364,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.93 [0.76-1.13],0.472912181159388,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.93 [0.77-1.13],0.475462143557157,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.63 [0.4-6.6],0.491492570872363,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.21 [0.71-2.06],0.492548818920325,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CST3,Cystatin-C,Inverse variance weighted,10,0.91 [0.68-1.21],0.496166606368517,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.12 [0.81-1.53],0.501089229034612,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.05 [0.9-1.23],0.505860924291521,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.84 [0.5-1.4],0.507995915925467,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LGALS9,Galectin-9,Inverse variance weighted,26,1.07 [0.87-1.31],0.515743719083765,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.78 [0.36-1.67],0.516840290591405,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SEPTIN8,Septin-8,Inverse variance weighted,2,0.8 [0.41-1.57],0.525317431102941,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.09 [0.83-1.44],0.533378429908554,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PALM2,Paralemmin-2,Inverse variance weighted,8,0.89 [0.6-1.3],0.536895107047219,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.25 [0.61-2.54],0.546915352496507,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.71 [0.23-2.19],0.547079863604534,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.94 [0.77-1.15],0.54714470275254,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.82 [0.43-1.57],0.550209213366853,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.84 [0.48-1.49],0.556378667973201,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CFD,Complement factor D,Inverse variance weighted,11,0.91 [0.67-1.24],0.556643333455242,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.17 [0.69-1.99],0.558878474016062,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.77 [0.32-1.88],0.568460817542669,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.58 [0.33-7.56],0.568748812472325,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.92 [0.68-1.24],0.571303224453259,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.3 [0.52-3.27],0.572819102987457,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.11 [0.77-1.59],0.574258179692556,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.12 [0.76-1.64],0.577582299257965,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KLK8,Kallikrein-8,Inverse variance weighted,12,0.92 [0.68-1.24],0.577827205950756,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CHGB,Secretogranin-1,Inverse variance weighted,27,0.96 [0.82-1.12],0.581720122144483,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PGF,Placenta growth factor,Inverse variance weighted,2,0.5 [0.04-5.76],0.582024626277491,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.2 [0.63-2.3],0.583006354918553,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.9 [0.62-1.31],0.58431209834321,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.05 [0.87-1.27],0.589456817824829,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NECTIN4,Nectin-4,Inverse variance weighted,7,0.93 [0.7-1.23],0.596366742438934,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD46,Membrane cofactor protein,Wald ratio,1,0.75 [0.26-2.19],0.599984623066348,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.06 [0.86-1.31],0.608927349181056,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PALM,Paralemmin-1,Inverse variance weighted,6,0.89 [0.55-1.43],0.615973540412273,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CDH3,Cadherin-3,Inverse variance weighted,2,1.8 [0.18-18.06],0.618925550227649,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.87 [0.49-1.54],0.626547905047275,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,AREG,Amphiregulin,Inverse variance weighted,3,1.16 [0.63-2.15],0.629097773621979,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.24 [0.51-3.05],0.637636510923646,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPP1,Osteopontin,Inverse variance weighted,8,0.82 [0.36-1.86],0.639683555676123,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.59 [0.06-5.41],0.641664050506431,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MMP3,Stromelysin-1,Inverse variance weighted,34,0.95 [0.78-1.17],0.6449053936593,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.08 [0.77-1.53],0.652330690103164,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.77 [0.24-2.42],0.652962070731367,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CALB1,Calbindin,Inverse variance weighted,2,1.41 [0.31-6.4],0.653894756401227,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,0.77 [0.24-2.46],0.655937263286162,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.15 [0.62-2.11],0.657932358890241,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.92 [0.65-1.32],0.662377701182416,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,0.97 [0.86-1.1],0.662574045457241,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.93 [0.66-1.31],0.663888275716278,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.91 [0.58-1.42],0.664195925948108,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.93 [0.67-1.29],0.665478350121745,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.87 [0.46-1.65],0.665804414049342,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.94 [0.7-1.25],0.666419700857467,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.03 [0.88-1.21],0.679165993934934,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,VWC2,Brorin,Inverse variance weighted,22,1.05 [0.83-1.33],0.680501600053916,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.06 [0.79-1.43],0.69895386252813,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.96 [0.78-1.18],0.700012866092612,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.85 [0.37-1.97],0.705179247039187,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SDC1,Syndecan-1,Inverse variance weighted,2,1.14 [0.58-2.26],0.707306108497055,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.93 [0.63-1.37],0.70910068783881,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.91 [0.57-1.47],0.711712652646394,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,OGN,Mimecan,Inverse variance weighted,30,1.04 [0.84-1.28],0.713296266405371,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.32 [0.3-5.88],0.715697766244977,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,0.93 [0.65-1.35],0.71623117143377,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.97 [0.81-1.16],0.72329932759767,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LGALS1,Galectin-1,Inverse variance weighted,6,0.93 [0.61-1.4],0.724879161257161,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MDK,Midkine,Inverse variance weighted,4,0.9 [0.48-1.67],0.728498548138634,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.25 [0.36-4.35],0.728917242569113,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.98 [0.86-1.11],0.729172971455487,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.1 [0.63-1.93],0.735227488792555,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.97 [0.82-1.16],0.740273816256867,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.96 [0.77-1.2],0.740621934926091,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.64 [0.05-8.99],0.741522695696536,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RGMB,RGM domain family member B,Inverse variance weighted,9,0.91 [0.5-1.66],0.749789511321099,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CHGA,Chromogranin-A,Inverse variance weighted,3,0.93 [0.57-1.5],0.755526611130536,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.02 [0.89-1.18],0.755594673832099,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.97 [0.77-1.21],0.75800709345408,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.85 [0.27-2.65],0.777582588060741,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,22,0.97 [0.81-1.18],0.788172330524095,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NECTIN2,Nectin-2,Inverse variance weighted,5,0.94 [0.57-1.52],0.790314423215132,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.16 [0.4-3.37],0.791367385587525,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.08 [0.6-1.97],0.791971387623854,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL19,Interleukin-19,Inverse variance weighted,11,1.04 [0.78-1.37],0.795925183181585,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.96 [0.7-1.31],0.795960380927222,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.94 [0.61-1.47],0.798661588083673,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.02 [0.85-1.23],0.807624103368172,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LMNB2,Lamin-B2,Wald ratio,1,1.31 [0.13-13.56],0.822367814903313,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.02 [0.84-1.25],0.824964561840672,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.94 [0.52-1.69],0.827857381178522,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1.06 [0.6-1.9],0.835421431673293,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.97 [0.76-1.25],0.837921200953507,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.04 [0.71-1.53],0.838669033470557,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GUCA2A,Guanylin,Inverse variance weighted,9,0.96 [0.63-1.46],0.84358941096927,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRSS8,Prostasin,Inverse variance weighted,5,0.93 [0.4-2.12],0.855036383053311,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.01 [0.87-1.18],0.856359566760998,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.01 [0.87-1.17],0.860397405431462,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1.01 [0.9-1.14],0.863081512214665,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.06 [0.51-2.2],0.871805083720459,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.98 [0.73-1.31],0.874352503620286,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.98 [0.75-1.27],0.875269130286341,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL17C,Interleukin-17C,Inverse variance weighted,3,1.06 [0.53-2.13],0.877044050591864,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.98 [0.76-1.27],0.8773140205815,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LAYN,Layilin,Inverse variance weighted,20,0.98 [0.74-1.29],0.884039517647219,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ANG,Angiogenin,Inverse variance weighted,19,1.02 [0.83-1.24],0.884989387065198,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.97 [0.64-1.47],0.894310506310938,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CTSV,Cathepsin L2,Inverse variance weighted,11,0.98 [0.7-1.38],0.902410205962202,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.04 [0.55-1.96],0.902582076393303,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.97 [0.57-1.64],0.905723201832014,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DSG3,Desmoglein-3,Inverse variance weighted,7,0.98 [0.69-1.4],0.909898140354854,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.03 [0.65-1.62],0.915531245548028,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.99 [0.86-1.15],0.917412721734935,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.98 [0.61-1.56],0.9190474533708,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.96 [0.46-2.02],0.920048182214966,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.03 [0.6-1.75],0.92198422121782,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,0.99 [0.76-1.29],0.927164977399356,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.98 [0.59-1.63],0.928234895096021,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.99 [0.76-1.28],0.93604632458699,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.03 [0.45-2.34],0.943337879493216,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CST6,Cystatin-M,Inverse variance weighted,2,0.98 [0.61-1.58],0.944847102254686,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CDH1,Cadherin-1,Wald ratio,1,0.94 [0.12-7.2],0.949098360593746,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,20,1 [0.86-1.16],0.950254480793942,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,1 [0.83-1.19],0.958454474861134,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD302,CD302 antigen,Inverse variance weighted,9,1.01 [0.71-1.44],0.961479364690117,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.01 [0.77-1.32],0.964546431721912,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,AGRN,Agrin,Inverse variance weighted,17,0.99 [0.75-1.32],0.971678177667057,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.73-1.36],0.988199287590883,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.99 [0.45-2.22],0.989372418973783,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FAM3B,Protein FAM3B,Inverse variance weighted,18,1 [0.85-1.17],0.993499907760203,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LGALS4,Galectin-4,Inverse variance weighted,4,1 [0.56-1.8],0.994930207214164,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1 [0.82-1.22],0.995012182058846,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1 [0.75-1.33],0.996407474977132,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,OCLN,Occludin,Inverse variance weighted,2,1 [0.48-2.07],0.997051091470575,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1 [0.77-1.31],0.998538117744613,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,THBD,Thrombomodulin,Inverse variance weighted,5,1 [0.52-1.9],0.998691629771913,cis
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.3 [0.16-0.57],0.000269832437671038,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,2.03 [1.33-3.1],0.000954587870232118,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,2.47 [1.38-4.42],0.00235602894097322,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,24.75 [2.43-252.42],0.00675856047883876,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,0.21 [0.07-0.69],0.00953019872289368,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.78 [1.11-2.85],0.0174765183827288,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,12.87 [1.53-108.2],0.0186923853518922,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.51 [0.29-0.9],0.0195536695950859,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,2.01 [1.11-3.62],0.0203422377906565,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,3.22 [1.2-8.63],0.0203906750180936,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.38 [1.03-1.84],0.0310394324021363,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MDK,Midkine,Inverse variance weighted,14,1.72 [1.04-2.83],0.03367221004819,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.18 [0.03-0.91],0.0385100649945204,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.38 [0.15-0.95],0.0387711207634532,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PI3,Elafin,Inverse variance weighted,18,1.34 [1.01-1.78],0.0404932387384077,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.17 [0.03-0.99],0.0482612659347752,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CFD,Complement factor D,Wald ratio,1,7.28 [0.98-53.99],0.05223536728076,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,5.92 [0.95-37.07],0.0573450048224691,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,4.69 [0.94-23.39],0.0595511631125093,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.44 [0.98-2.12],0.0613749291838144,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.31 [0.08-1.11],0.0724352824686628,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,0.71 [0.48-1.04],0.0768442004493556,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.76 [0.94-3.29],0.0771194053090209,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD160,CD160 antigen,Inverse variance weighted,24,1.38 [0.97-1.97],0.0771854349515331,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CHGA,Chromogranin-A,Inverse variance weighted,5,2.01 [0.92-4.37],0.0779405059372374,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.75 [0.54-1.03],0.0797581931356273,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.41 [0.96-2.09],0.0797832204825953,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.58 [0.94-2.63],0.081458573124332,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MMP3,Stromelysin-1,Inverse variance weighted,4,3.02 [0.86-10.6],0.0850557588497147,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.69 [0.45-1.06],0.0908410975856433,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,50,0.83 [0.66-1.03],0.0931221896189971,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,3.75 [0.8-17.72],0.0947709136763497,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CST3,Cystatin-C,Inverse variance weighted,3,0.34 [0.09-1.21],0.0960222501087688,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,8.37 [0.68-103.09],0.0972739172089858,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.2 [0.97-1.49],0.0976837925456553,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRSS8,Prostasin,Inverse variance weighted,14,1.46 [0.93-2.29],0.09783074873159,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.88 [0.76-1.03],0.117842771668325,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.93 [0.84-4.45],0.121341640670739,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PGA4,Pepsin A-4,Inverse variance weighted,7,0.57 [0.27-1.18],0.127363359730718,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.62 [0.87-3.02],0.129656176015029,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,OCLN,Occludin,Inverse variance weighted,2,0.37 [0.1-1.39],0.140568998070187,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.43 [0.14-1.33],0.142554708170472,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.31 [0.91-1.9],0.148529501055241,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.49 [0.84-2.64],0.169481315959161,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.65 [0.8-3.42],0.175937261484359,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.9 [0.77-1.05],0.179215862087395,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.37 [0.09-1.58],0.180135707512439,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REN,Renin,Inverse variance weighted,8,1.7 [0.78-3.74],0.184695798067099,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.3 [0.88-1.92],0.185450847066111,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.66 [0.36-1.23],0.190220833093578,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NECTIN4,Nectin-4,Inverse variance weighted,4,2.04 [0.69-6.06],0.200165840913365,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.47 [0.15-1.51],0.206897006306178,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.21 [0.9-1.62],0.212545195314171,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.84 [0.63-1.11],0.216988415421631,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.36 [0.07-1.84],0.220418974420868,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.37 [0.07-1.83],0.22043478667289,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NUCB2,Nucleobindin-2,Inverse variance weighted,2,2.55 [0.56-11.53],0.225688467283936,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,VWC2,Brorin,Inverse variance weighted,12,0.64 [0.32-1.31],0.226935617330038,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.55 [0.2-1.47],0.230978620224257,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,2.01 [0.64-6.35],0.231797277890194,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.39 [0.08-1.83],0.232633386802103,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KLK6,Kallikrein-6,Inverse variance weighted,2,2.14 [0.6-7.63],0.241384673196787,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.55 [0.2-1.5],0.241977765904758,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SEPTIN8,Septin-8,Inverse variance weighted,4,0.6 [0.25-1.42],0.242538557278492,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.44 [0.78-2.67],0.242999970647361,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.39 [0.8-2.43],0.244078788898128,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.32 [0.04-2.23],0.247657629623587,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,2.07 [0.6-7.12],0.248267166393218,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.48 [0.76-2.87],0.251435990197985,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,3.15 [0.43-23.23],0.259347304670461,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.89 [0.74-1.09],0.26093615148481,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SCG2,Secretogranin-2,Inverse variance weighted,2,2.4 [0.52-11.05],0.261256908650585,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.59 [0.23-1.49],0.262749913491673,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.71 [0.39-1.3],0.270288336964441,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.86 [0.66-1.12],0.270667159579168,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.69 [0.36-1.34],0.27523534752098,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,0.78 [0.5-1.23],0.282364206740727,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.32 [0.04-2.61],0.287276705579105,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.62 [0.25-1.53],0.299525345635102,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.43 [0.72-2.82],0.305343117793621,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RETN,Resistin,Inverse variance weighted,19,1.22 [0.83-1.81],0.308876560815002,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.9 [0.73-1.1],0.308956638868126,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.56 [0.18-1.71],0.309853336549828,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,OGN,Mimecan,Inverse variance weighted,37,1.11 [0.9-1.38],0.311682794449616,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.9 [0.72-1.11],0.316371056903542,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,0.71 [0.37-1.39],0.320148494078788,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CSTB,Cystatin-B,Inverse variance weighted,23,0.9 [0.73-1.11],0.322924067043552,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,2.83 [0.36-22.5],0.324880449146831,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.35 [0.74-2.49],0.326993224840732,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.24 [0.01-4.3],0.329367456253091,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.46 [0.1-2.2],0.331816231909958,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.56 [0.17-1.82],0.333535532452962,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.55 [0.63-3.8],0.33528878560809,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GDF15,Growth/differentiation factor 15,Wald ratio,1,3.85 [0.24-62.7],0.343209721299114,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.86 [0.63-1.18],0.343260429087015,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PGF,Placenta growth factor,Inverse variance weighted,5,1.44 [0.68-3.04],0.343688269501871,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,0.91 [0.75-1.11],0.344322604064488,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CDH1,Cadherin-1,Inverse variance weighted,16,0.87 [0.65-1.16],0.346116039227386,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CST6,Cystatin-M,Inverse variance weighted,26,0.83 [0.56-1.23],0.349161298779999,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.76 [0.44-1.34],0.350053967832543,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.11 [0.89-1.39],0.352352207387267,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.92 [0.78-1.1],0.360920932783756,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.95 [0.85-1.06],0.36152041931233,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.06 [0.93-1.21],0.365621720623122,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LGALS4,Galectin-4,Inverse variance weighted,15,1.12 [0.88-1.42],0.367014109382542,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.27 [0.75-2.16],0.367171397378804,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.18 [0.82-1.7],0.368086518209298,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.36 [0.69-2.68],0.370255604255592,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DSC2,Desmocollin-2,Inverse variance weighted,16,0.88 [0.66-1.17],0.380740138692797,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.8 [0.48-1.33],0.385690622640603,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.22 [0.78-1.93],0.3859560413807,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GAST,Gastrin,Inverse variance weighted,9,0.77 [0.42-1.4],0.388595763197338,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KLK8,Kallikrein-8,Inverse variance weighted,5,1.54 [0.57-4.18],0.393142345070062,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL17C,Interleukin-17C,Inverse variance weighted,5,0.67 [0.26-1.69],0.395844930035926,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SDC1,Syndecan-1,Inverse variance weighted,12,1.33 [0.69-2.57],0.39766369428734,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.41 [0.05-3.31],0.404496789318314,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.34 [0.67-2.71],0.409667921873896,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.7 [0.3-1.64],0.411083191594214,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.66 [0.25-1.79],0.416955635812236,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.24 [0.73-2.09],0.421611677046252,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,BSG,Basigin,Inverse variance weighted,6,1.4 [0.61-3.19],0.429185541431156,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.78 [0.41-1.46],0.429290458986514,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.75 [0.36-1.54],0.430351897493316,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.78 [0.42-1.45],0.431763764336651,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,THBD,Thrombomodulin,Inverse variance weighted,11,1.15 [0.81-1.63],0.436593466989821,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,AREG,Amphiregulin,Inverse variance weighted,5,1.51 [0.53-4.3],0.441008225501186,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,0.88 [0.63-1.22],0.44918361640912,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD302,CD302 antigen,Inverse variance weighted,11,0.83 [0.51-1.35],0.452324655841718,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,0.76 [0.38-1.55],0.453173505813898,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.45 [0.55-3.85],0.453900824946743,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.64 [0.2-2.07],0.46066929593514,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LGALS9,Galectin-9,Inverse variance weighted,36,1.07 [0.88-1.3],0.476705012970672,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.88 [0.62-1.25],0.477818752010392,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCN3,CCN family member 3,Inverse variance weighted,17,0.9 [0.67-1.2],0.47808848351923,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.71 [0.27-1.85],0.479184227764318,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.84 [0.52-1.36],0.487629276339436,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.79 [0.41-1.53],0.489550242239442,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.87 [0.59-1.29],0.491015675508339,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.54 [0.45-5.2],0.491255116436778,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.93 [0.75-1.15],0.497104799546295,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD27,CD27 antigen,Inverse variance weighted,9,0.79 [0.39-1.59],0.500399211731052,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.3 [0.61-2.77],0.501873911782596,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.12 [0.8-1.59],0.503815498140926,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.72 [0.28-1.87],0.503950209800756,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.75 [0.32-1.76],0.5075578800463,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.71 [0.26-1.96],0.508635341456363,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.81 [0.42-1.54],0.5162074297724,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.27 [0.62-2.58],0.51670636673591,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MMP7,Matrilysin,Wald ratio,1,0.75 [0.32-1.8],0.526607831029188,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.92 [0.71-1.19],0.533375059406301,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.06 [0.88-1.29],0.535896259018939,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,1.15 [0.74-1.79],0.54521379928221,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CX3CL1,Fractalkine,Inverse variance weighted,12,0.84 [0.48-1.48],0.546940262621564,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.86 [0.52-1.41],0.547807746751334,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.69 [0.3-9.54],0.550834446593437,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,COLEC12,Collectin-12,Inverse variance weighted,3,0.67 [0.18-2.52],0.552213497435735,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.73 [0.26-2.07],0.553978385575947,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PALM2,Paralemmin-2,Inverse variance weighted,9,0.89 [0.61-1.3],0.556792207104126,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CTSV,Cathepsin L2,Inverse variance weighted,34,1.08 [0.83-1.4],0.563103902014674,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.15 [0.72-1.84],0.56731411106913,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.58 [0.33-7.56],0.568748812472325,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.76 [0.3-1.96],0.574109642007854,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.15 [0.7-1.91],0.57888915638663,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.66 [0.15-2.87],0.58005272584654,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.82 [0.4-1.68],0.581130106283321,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,AMBP,Protein AMBP,Inverse variance weighted,5,1.19 [0.64-2.21],0.582725974224902,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.06 [0.85-1.33],0.586835696412346,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.96 [0.82-1.12],0.588406915251913,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.78 [0.31-1.97],0.594663393895114,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.82 [0.18-18.75],0.614204372499349,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.93 [0.66-1.29],0.647193368511811,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.03 [0.9-1.19],0.654413388174281,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPP1,Osteopontin,Inverse variance weighted,13,0.88 [0.49-1.56],0.654753388909336,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.86 [0.45-1.66],0.655991165753395,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.11 [0.69-1.8],0.658656338857423,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.82 [0.34-1.99],0.659410702020416,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.89 [0.51-1.53],0.66206109370247,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.88 [0.48-1.61],0.669493103885817,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.81 [0.3-2.2],0.673992212574678,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.98 [0.87-1.09],0.675110920951102,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.23 [0.47-3.2],0.675763476612799,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.66 [0.15-18.11],0.67586195231883,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.61 [0.17-15.25],0.67590391810292,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,AGRN,Agrin,Inverse variance weighted,14,0.9 [0.56-1.45],0.676927403205533,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.89 [0.51-1.54],0.678060618048404,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.64 [0.08-5.29],0.679469568064038,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.09 [0.73-1.62],0.683483481018318,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,1.09 [0.7-1.7],0.69169504674455,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.09 [0.7-1.7],0.695882478943508,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.65 [0.07-5.95],0.700297605421881,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.32 [0.32-5.49],0.703631564920067,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.13 [0.6-2.11],0.704719666717474,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.87 [0.41-1.83],0.705249742522056,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.12 [0.63-1.98],0.707299568687895,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRSS2,Trypsin-2,Inverse variance weighted,17,1.07 [0.74-1.56],0.709659221120995,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CALB1,Calbindin,Inverse variance weighted,9,1.17 [0.5-2.78],0.714363019723338,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CALCA,Calcitonin,Inverse variance weighted,13,1.11 [0.62-1.99],0.721033710023339,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.43 [0.19-10.65],0.725782267596071,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.39 [0.22-8.93],0.726239756453241,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.05 [0.79-1.41],0.731117716944644,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD99,CD99 antigen,Inverse variance weighted,4,0.88 [0.4-1.91],0.73755028555715,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.19 [0.43-3.31],0.73823425126278,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.07 [0.71-1.63],0.738824175806735,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.82 [0.25-2.7],0.742424006217536,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.06 [0.76-1.48],0.743173704738918,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,WNT9A,Protein Wnt-9a,Wald ratio,1,1.55 [0.11-22.4],0.746542844318963,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.68 [0.06-7.16],0.748605147684213,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPON2,Spondin-2,Inverse variance weighted,3,1.23 [0.34-4.44],0.748720277827599,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.42 [0.16-12.5],0.750860808244911,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DSG3,Desmoglein-3,Inverse variance weighted,27,1.04 [0.81-1.33],0.754443100909482,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.22 [0.35-4.18],0.755895682536142,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.94 [0.64-1.39],0.759334983038165,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.91 [0.5-1.66],0.759366762212823,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.85 [0.29-2.45],0.761573780055964,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,1.14 [0.49-2.64],0.763433437730333,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.09 [0.61-1.95],0.767322103344952,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.87 [0.36-2.14],0.767541710968249,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.98 [0.84-1.14],0.769913122481337,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.09 [0.58-2.05],0.777599016258842,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.37 [0.15-12.54],0.779452708073067,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.9 [0.43-1.9],0.788589785086272,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.12 [0.5-2.5],0.789203240118841,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.96 [0.72-1.28],0.793128486024573,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PSAP,Prosaposin,Inverse variance weighted,13,1.05 [0.74-1.48],0.79851793682809,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,0.95 [0.67-1.36],0.799331923426212,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL19,Interleukin-19,Inverse variance weighted,10,0.96 [0.73-1.27],0.800197117255002,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PENK,Proenkephalin-A,Inverse variance weighted,15,0.94 [0.59-1.5],0.804214123643358,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,GUCA2A,Guanylin,Inverse variance weighted,7,0.91 [0.44-1.89],0.804225692421972,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.92 [0.49-1.74],0.806662339516833,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RSPO3,R-spondin-3,Inverse variance weighted,5,1.16 [0.36-3.74],0.809336143264547,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.08 [0.55-2.11],0.81878619762422,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.15 [0.33-4.04],0.824373726531675,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.88 [0.29-2.72],0.827069632849836,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.09 [0.51-2.31],0.828874180237605,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.83 [0.15-4.65],0.829197128395719,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.91 [0.37-2.23],0.830551591943546,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.03 [0.76-1.41],0.837904024258315,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RGMB,RGM domain family member B,Inverse variance weighted,5,1.18 [0.24-5.88],0.840878479095397,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.88 [0.25-3.13],0.841310558887983,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.29 [0.11-15.37],0.842652570790232,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.93 [0.44-1.95],0.84383999391631,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.04 [0.68-1.6],0.845957485506516,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.08 [0.49-2.38],0.854046979795882,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.04 [0.66-1.66],0.855807385187441,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.08 [0.48-2.44],0.856045454019424,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.04 [0.67-1.61],0.858012320305515,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NECTIN2,Nectin-2,Inverse variance weighted,3,0.79 [0.06-10.85],0.858294322098608,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LMNB2,Lamin-B2,Inverse variance weighted,8,0.93 [0.43-2.01],0.858774007275517,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.02 [0.79-1.33],0.85992951985727,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.22 [0.12-12.37],0.868417784490967,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD83,CD83 antigen,Inverse variance weighted,14,0.95 [0.49-1.84],0.868639138942298,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PALM,Paralemmin-1,Inverse variance weighted,4,0.89 [0.23-3.52],0.869444976568126,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,XG,Glycoprotein Xg,Inverse variance weighted,2,1.14 [0.23-5.63],0.871227135112763,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.06 [0.53-2.11],0.874200452024164,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.04 [0.64-1.68],0.879192917222315,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.99 [0.81-1.2],0.882989320444646,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.98 [0.74-1.3],0.889545326621094,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.02 [0.75-1.4],0.897087696152087,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.05 [0.52-2.11],0.900382086577673,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.14 [0.13-10.23],0.903790294463978,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.99 [0.81-1.2],0.904490573007021,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.91 [0.19-4.27],0.904972745955783,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.03 [0.65-1.62],0.915531245548028,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.04 [0.49-2.19],0.920004878092721,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.04 [0.49-2.2],0.920761980585641,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.97 [0.55-1.73],0.921403826238453,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.99 [0.77-1.27],0.924483775115417,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,UMOD,Uromodulin,Inverse variance weighted,34,0.99 [0.72-1.35],0.928835627612446,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LAYN,Layilin,Inverse variance weighted,3,0.89 [0.07-10.97],0.929372187359151,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CHGB,Secretogranin-1,Inverse variance weighted,7,0.96 [0.4-2.3],0.93016296104091,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.04 [0.44-2.47],0.930220874832958,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,KLK11,Kallikrein-11,Inverse variance weighted,13,1.02 [0.63-1.65],0.930453145129959,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.97 [0.43-2.17],0.932945092973108,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.02 [0.56-1.88],0.939420874802266,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,ANG,Angiogenin,Inverse variance weighted,8,1.03 [0.43-2.5],0.942108048189905,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,0.98 [0.51-1.89],0.958363863426945,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,60,1 [0.87-1.16],0.964542657058235,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.97 [0.27-3.55],0.964910505178796,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPON1,Spondin-1,Inverse variance weighted,4,1.02 [0.38-2.69],0.976030241094722,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.98 [0.29-3.37],0.976408545182068,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.95 [0.04-23.34],0.97744066474655,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.01 [0.42-2.43],0.980187929094952,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.99 [0.56-1.77],0.984559035823237,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1 [0.69-1.47],0.985926570830792,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CDH3,Cadherin-3,Inverse variance weighted,10,1 [0.57-1.73],0.987009746827078,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,9,1.01 [0.49-2.07],0.988214734250385,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.01 [0.38-2.69],0.990153417877105,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1 [0.64-1.56],0.990513849679766,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.99 [0.2-4.91],0.994053481481258,trans
Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.01 [0.25-4.12],0.994116042484253,trans
